136 related articles for article (PubMed ID: 3132571)
21. [Experience with the use of nitroderm--a prolonged-action nitroglycerin preparation].
Mikunis RI; Monastyrskiĭ IuI; Zhebel' VN; Serkova VK; Bogach NT
Kardiologiia; 1987 Mar; 27(3):99-101. PubMed ID: 3108565
[No Abstract] [Full Text] [Related]
22. [Pharmacodynamics of a nitroglycerin ointment in patients with stenocardia of effort].
Romakov AIu; Sagirov AM; Sumarokov AB; Mazur NA
Kardiologiia; 1985 Apr; 25(4):41-4. PubMed ID: 3927053
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris.
Johnson SM; Mauritson DR; Corbett JR; Woodward W; Willerson JT; Hillis LD
Am J Med; 1981 Sep; 71(3):443-51. PubMed ID: 7282732
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of verapamil and propranolol in patients with angina pectoris.
de Oliveira JM
Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():45-50. PubMed ID: 98137
[No Abstract] [Full Text] [Related]
25. [Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Zhiliaev EV; Urzhumova TV; Glazunov AV; Sorokoletov SM; Dzhanashiia PKh
Ter Arkh; 2000; 72(8):20-3. PubMed ID: 11019420
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacodynamic comparison of propranolol and verapamil in exertion stenocardia].
Sumarokov AB; Romakov AIu; Sagirov AM; Iurkova VB; Mazur NA
Klin Med (Mosk); 1984 Mar; 62(3):42-6. PubMed ID: 6716929
[No Abstract] [Full Text] [Related]
27. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
BLoem TJ; Lindner PC
Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
[TBL] [Abstract][Full Text] [Related]
28. Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort.
Winniford MD; Huxley RL; Hillis LD
J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):492-8. PubMed ID: 6338082
[No Abstract] [Full Text] [Related]
29. [Anti-angina effectiveness of sustak and obzidan in the acute period of myocardial infarct].
Kavtaradze VG; Iosava KV; Machavariani PT; Kveselava MV
Kardiologiia; 1980 Nov; 20(11):84-6. PubMed ID: 6777576
[TBL] [Abstract][Full Text] [Related]
30. [The comparative efficacy of individually adjusted doses of proxodolol and propranolol for one-time and regular administration in stenocardia patients].
Bochkareva EV; Kokurina EV; Metelitsa VI; Pankina VA
Eksp Klin Farmakol; 1994; 57(3):51-4. PubMed ID: 7914122
[TBL] [Abstract][Full Text] [Related]
31. Angiologic assessment of the hemodynamic effects of sustained release nitroglycerin in patients with angina pectoris.
Thompson EJ; Glass P; Torres C; Arora J; Piccone VA
Angiology; 1973 Sep; 24(8):508-14. PubMed ID: 4199545
[No Abstract] [Full Text] [Related]
32. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
Johnston DL; Manyari DE; Kostuk WJ
Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
[TBL] [Abstract][Full Text] [Related]
33. [Characteristics of patients with ischemic heart disease under dispensary observation in a regional polyclinic and the evaluation of anti-angina therapy conducted under dispensary conditions].
Bekhbudova DA; Kokurina EV; Ostrovskaia TP; Bochkareva EV; Urumbaev RK
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):95-100. PubMed ID: 3924078
[TBL] [Abstract][Full Text] [Related]
34. [Relation of the anti-anginal effect and blood serum level of verapamil in patients with exercise-induced stenocardia].
Slastnikova ID; Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI
Kardiologiia; 1990 Feb; 30(2):20-4. PubMed ID: 2190039
[TBL] [Abstract][Full Text] [Related]
35. [Use of verapamil for treating patients with unstable stenocardia].
Karpov IuA; Noeva EA
Kardiologiia; 1985 May; 25(5):38-44. PubMed ID: 4021296
[TBL] [Abstract][Full Text] [Related]
36. [Antianginal and hemodynamic effect of propranolol and atenolol in patients with exertion angina].
Desiatnichenko VM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):71-5. PubMed ID: 6508931
[TBL] [Abstract][Full Text] [Related]
37. Peripheral hemodynamic effects of oral controlled-release nitroglycerin (Nitrong) in man.
Hirshleifer I
Curr Ther Res Clin Exp; 1973 Apr; 15(4):158-64. PubMed ID: 4633276
[No Abstract] [Full Text] [Related]
38. [Anti-anginal action, by opposite mechanisms, of nitroglycerin and propranolol].
Giani P; Folli G; Bruno L; Binaghi G; Rizzato GF; Bandera L
Cuore Circ; 1969 Oct; 53(5):213-32. PubMed ID: 4984065
[No Abstract] [Full Text] [Related]
39. [Synergism of the anti-angina effect of obzidan and finoptin in patients with effort stenocardia].
Sagirov AM; Romakov AIu; Sumarokov AB; Mazur NA
Kardiologiia; 1985 Jul; 25(7):81-5. PubMed ID: 4057745
[TBL] [Abstract][Full Text] [Related]
40. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
